Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease [0.03%]
帕金森病患者主观认知抱怨与新发功能障碍之间的关联
Daniel Weintraub,Connie Marras,Amy Amara et al.
Daniel Weintraub et al.
Background: Early identification of subjective cognitive complaints (SCC) in Parkinson's disease (PD) may improve patient care if it predicts cognition-related functional impairment (CFI). ...
Novel Insights into the Genetic Basis of Progressive Supranuclear Palsy in Asian-Indian Population [0.03%]
亚洲印度人群体中进行性核上性麻痹遗传基础的新见解
Saikat Dey,Monojit Debnath,Ramchandra Yelamanchi et al.
Saikat Dey et al.
Defining the Genetic Landscape of Congenital Mirror Movements in 80 Affected Individuals [0.03%]
80名患者定义先天镜像运动的遗传特征
Meagan L Collins Hutchinson,Judith St-Onge,Sabrina Schlienger et al.
Meagan L Collins Hutchinson et al.
Background: Congenital mirror movements (CMM) is a rare neurodevelopmental disorder characterized by involuntary movements from one side of the body that mirror voluntary movements on the opposite side. To date, five gene...
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study [0.03%]
布司派隆和佐洛米曲坦组合治疗异动症：随机、对照、交叉研究
Peter A LeWitt,Glenn T Stebbins,Kenneth Vielsted Christensen et al.
Peter A LeWitt et al.
Background: Preclinical evidence suggests that co-administration of the 5-HT1A agonist buspirone and the 5-HT1B/1D agonist zolmitriptan act synergistically to reduce dyskinesia to a greater extent than that achieved by ei...
Randomized Controlled Trial
Movement disorders : official journal of the Movement Disorder Society. 2024 Mar;39(3):613-618. DOI:10.1002/mds.29713 2024
Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track? [0.03%]
国际运动障碍学会前期帕金森病标准的挑战和未来：我们是否走在正确的道路上？
Kristina Kulcsarova,Matej Skorvanek
Kristina Kulcsarova
An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm [0.03%]
Dipraglurant治疗眼睑痉挛的探索性随机双盲临床试验
Gamze Kilic-Berkmen,Hodam Kim,Dongdong Chen et al.
Gamze Kilic-Berkmen et al.
Background: Blepharospasm is treated with botulinum toxin, but obtaining satisfactory results is sometimes challenging. Objective: The ...
Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds [0.03%]
《关于帕金森病患者使用大麻产品的认知安全性的回应：需要坚实科学证据来指导当前处于困境中的临床医生和患者》
Christopher H Domen,Stefan Sillau,Ying Liu et al.
Christopher H Domen et al.
Genetics of Parkinson's Disease in Underrepresented Populations: New Studies Pave the Way [0.03%]
代表性不足人群中帕金森病的遗传学：新研究铺平了道路
Ziv Gan-Or,Roy N Alcalay
Ziv Gan-Or
Circulating Extracellular Vesicles as a Potential Mediator of Synuclein Pathology in the Gut [0.03%]
循环的细胞外囊泡可能是肠道中核蛋白病理学的潜在介导因子
Timothy R Sampson
Timothy R Sampson
The spread of pathological alpha-synuclein (aSyn) from the gastrointestinal tract to the brain, or the brain to the intestine, is of increasing interest given observations in experimental models. While there has been a focus on neuronal-med...